title: Multiple sclerosis: Fingolimod failure in progressive MS INFORMS future trials.
authors.affiliation: Mellen Center for Multiple Sclerosis Treatment and Research in the Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44915, USA.
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Smith
authors.affiliation: Mellen Center for Multiple Sclerosis Treatment and Research in the Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44915, USA.
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Cohen
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D018450:Disease Progression; D000068876:Fingolimod Hydrochloride / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D015337:Multicenter Studies as Topic; D020528:Multiple Sclerosis, Chronic Progressive / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D017211:Treatment Failure
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride